van Tuyl, Lilian H D <br/><br/>
Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis.  [electronic resource] 

 -  Annals of the rheumatic diseases  May 2010 
 - 807-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/ard.2009.108027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Rheumatoid--diagnostic imaging<br/>Disease Progression<br/>Drug Therapy, Combination<br/>Epidemiologic Methods<br/>Female<br/>Humans<br/>Male<br/>Methotrexate--adverse effects<br/>Middle Aged<br/>Prednisolone--adverse effects<br/>Radiography<br/>Sulfasalazine--adverse effects<br/>Treatment Outcome